{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "Analysis type": "Multivariate Cox proportional hazards regression",
                    "Outcome assessed": "Overall survival (OS)",
                    "Treatment phase": "First phase I treatment",
                    "Variable": "ECOG performance status",
                    "Contrast": "> 0 vs. 0"
                },
                "measures": "[Hazard ratio (95% CI), P value]",
                "outcomes": "[1.47 (0.90, 2.41), 0.12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Variable": "ECOG performance status",
                    "Contrast": "> 0 vs. 0",
                    "Analysis Type": "multivariate Cox proportional hazards regression",
                    "Outcome Measure": "overall survival",
                    "Treatment Phase": "first phase I"
                },
                "measures": "[Hazard ratio, 95% CI, p-value]",
                "outcomes": "[1.47, 0.90-2.41, 0.12]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Analysis type": "Multivariate Cox proportional hazards regression",
                    "Outcome assessed": "Overall survival (OS)",
                    "Treatment phase": "First phase I treatment",
                    "Variable": "Liver metastases",
                    "Contrast": "Yes vs. No"
                },
                "measures": "[Hazard ratio (95% CI), P value]",
                "outcomes": "[1.72 (1.01, 2.91), 0.045]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Variable": "Liver metastases",
                    "Contrast": "Yes vs. No",
                    "Analysis Type": "multivariate Cox proportional hazards regression",
                    "Outcome Measure": "overall survival",
                    "Treatment Phase": "first phase I"
                },
                "measures": "[Hazard ratio, 95% CI, p-value]",
                "outcomes": "[1.72, 1.01-2.91, 0.045]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Analysis type": "Multivariate Cox proportional hazards regression",
                    "Outcome assessed": "Overall survival (OS)",
                    "Treatment phase": "First phase I treatment",
                    "Variable": "No. of metastatic sites",
                    "Contrast": ">2 vs. <= 2"
                },
                "measures": "[Hazard ratio (95% CI), P value]",
                "outcomes": "[1.33 (0.9, 2.25), 0.28]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Variable": "No. of metastatic sites",
                    "Contrast": ">2 vs. <= 2",
                    "Analysis Type": "multivariate Cox proportional hazards regression",
                    "Outcome Measure": "overall survival",
                    "Treatment Phase": "first phase I"
                },
                "measures": "[Hazard ratio, 95% CI, p-value]",
                "outcomes": "[1.33, 0.9-2.25, 0-28]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Analysis type": "Multivariate Cox proportional hazards regression",
                    "Outcome assessed": "Overall survival (OS)",
                    "Treatment phase": "First phase I treatment",
                    "Variable": "Prior radiation therapy",
                    "Contrast": "Yes vs. No"
                },
                "measures": "[Hazard ratio (95% CI), P value]",
                "outcomes": "[1.58 (0.95, 2.61), 0.077]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Variable": "Prior radiation therapy",
                    "Contrast": "Yes vs. No",
                    "Analysis Type": "multivariate Cox proportional hazards regression",
                    "Outcome Measure": "overall survival",
                    "Treatment Phase": "first phase I"
                },
                "measures": "[Hazard ratio, 95% CI, p-value]",
                "outcomes": "[1.58, 0.95-2.61, 0.077]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Analysis type": "Multivariate Cox proportional hazards regression",
                    "Outcome assessed": "Overall survival (OS)",
                    "Treatment phase": "First phase I treatment",
                    "Variable": "Prior FOLFIRINOX",
                    "Contrast": "Yes vs. No"
                },
                "measures": "[Hazard ratio (95% CI), P value]",
                "outcomes": "[1.73 (1.01, 2.98), 0.046]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Variable": "Prior FOLFIRINOX",
                    "Contrast": "Yes vs. No",
                    "Analysis Type": "multivariate Cox proportional hazards regression",
                    "Outcome Measure": "overall survival",
                    "Treatment Phase": "first phase I"
                },
                "measures": "[Hazard ratio, 95% CI, p-value]",
                "outcomes": "[1.73, 1.01-2.98, 0.046]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Analysis type": "Multivariate Cox proportional hazards regression",
                    "Outcome assessed": "Overall survival (OS)",
                    "Treatment phase": "First phase I treatment",
                    "Variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                    "Contrast": "Yes vs. No"
                },
                "measures": "[Hazard ratio (95% CI), P value]",
                "outcomes": "[1.08 (0.58, 2.01), 0.80]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Variable": "Prior gemcitabine plus nab-paclitaxel treatment",
                    "Contrast": "Yes vs. No",
                    "Confidence Interval Lower": "0.58",
                    "Confidence Interval Upper": "2.01",
                    "Analysis Type": "multivariate Cox proportional hazards regression",
                    "Outcome Measure": "overall survival",
                    "Treatment Phase": "first phase I"
                },
                "measures": "[Hazard ratio, 95% CI, p-value]",
                "outcomes": "[1.08, 0.58-2.01, 0.80]"
            },
            "match": "yes"
        }
    ],
    "total_extracted_claims": 6,
    "total_ground_truth_claims": 6,
    "number_of_matches": 6
}